Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PURPOSE: We describe a case of occlusive vasculitis associated with intravitreal Faricimab (Vabysmo) injections. METHODS: A retrospective case report. RESULTS: A 52-year old man treated with monthly Faricimab injections for diabetic macula oedema presented with sudden reduced vision, new retinal hemorrhages, significant retinal vascular occlusions and ischemia. After screening for differential diagnoses was unremarkable, the patient was treated with oral and intravitreal steroid therapy under which the occlusive vasculitis was stabilized. CONCLUSION: Occlusive vasculitis, though rare, is a potential complication of Faricimab therapy. Comprehensive reporting and large-scale analyses are essential to better understand and manage this adverse event.

Original publication

DOI

10.1186/s12348-024-00429-7

Type

Journal article

Journal

J Ophthalmic Inflamm Infect

Publication Date

27/09/2024

Volume

14

Keywords

Diabetic retinopathy, Faricimab, Occlusive vasculitis, Vabysmo